These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32936550)

  • 1. [Deprescribing antihypertensive therapy].
    Tebib N; Wuerzner G
    Rev Med Suisse; 2020 Sep; 16(706):1690-1692. PubMed ID: 32936550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
    McIntyre C; McQuillan R; Bell C; Battistella M
    Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nursing home team-care deprescribing study: a stepped-wedge randomised controlled trial protocol.
    Kua CH; Yeo CYY; Char CWT; Tan CWY; Tan PC; Mak VS; Lee SWH; Leong IY
    BMJ Open; 2017 May; 7(5):e015293. PubMed ID: 28490560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive Deprescribing in Older Adults: a Practical Guide.
    Sheppard JP; Benetos A; McManus RJ
    Curr Hypertens Rep; 2022 Nov; 24(11):571-580. PubMed ID: 35881225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of deprescription by general practitioners in elderly people with different levels of dependence: cross-sectional study.
    Coelho T; Rosendo I; Seiça Cardoso C
    BMC Prim Care; 2024 Mar; 25(1):78. PubMed ID: 38431577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deprescribing in primary care in Portugal (DePil17-20): a three-phase observational and experimental study protocol.
    Simões PA; Santiago LM; Simões JA
    BMJ Open; 2018 Jul; 8(7):e019542. PubMed ID: 30018092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Deprescribing in nursing homes - which drugs and when?].
    Püllen R
    MMW Fortschr Med; 2023 Mar; 165(4):38-41. PubMed ID: 36826665
    [No Abstract]   [Full Text] [Related]  

  • 8. Strategies for Identifying Patients for Deprescribing of Blood Pressure Medications in Routine Practice: An Evidence Review.
    Sheppard JP; Benetos A; Bogaerts J; Gnjidic D; McManus RJ
    Curr Hypertens Rep; 2024 May; 26(5):225-236. PubMed ID: 38305846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isn't It Time We Stop Counting the Number of Drugs to Define Polypharmacy in This New Era of Deprescribing and What Related Outcomes Should Be Measured?
    Hanlon JT; Hajjar ER
    J Am Med Dir Assoc; 2018 Aug; 19(8):644-645. PubMed ID: 29861195
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials.
    Crisafulli S; Luxi N; Coppini R; Capuano A; Scavone C; Zinzi A; Vecchi S; Onder G; Sultana J; Trifirò G
    BMC Fam Pract; 2021 Oct; 22(1):208. PubMed ID: 34666689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MEDICATIONS DEPRESCRIBING IN ELDERLY NURSING HOME RESIDENTS].
    Aizen E; Hindawil E; Hijazi M; Merih A; Shahla H; Elyounes AA
    Harefuah; 2016 Mar; 155(3):145-9, 197. PubMed ID: 27305746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Deprescribing in nursing homes: comparative views of residents, their relatives, and healthcare professionals].
    Cateau D; Foley RA; Niquille A
    Rev Med Suisse; 2020 Nov; 16(714):2169-2171. PubMed ID: 33174699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypharmacy: Evaluating Risks and Deprescribing.
    Halli-Tierney AD; Scarbrough C; Carroll D
    Am Fam Physician; 2019 Jul; 100(1):32-38. PubMed ID: 31259501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Ecological Approach to Reducing Potentially Inappropriate Medication Use: Canadian Deprescribing Network.
    Tannenbaum C; Farrell B; Shaw J; Morgan S; Trimble J; Currie J; Turner J; Rochon P; Silvius J
    Can J Aging; 2017 Mar; 36(1):97-107. PubMed ID: 28091333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities.
    Ailabouni N; Mangin D; Nishtala PS
    Int J Clin Pharm; 2019 Feb; 41(1):167-178. PubMed ID: 30659492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive treatment in people of very old age with frailty: time for a paradigm shift?
    Shantsila E; Lip GYH; Shantsila A; Kurpas D; Beevers G; Gill PS; Williams NH
    J Hypertens; 2023 Oct; 41(10):1502-1510. PubMed ID: 37432893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people.
    Todd A; Jansen J; Colvin J; McLachlan AJ
    BMC Geriatr; 2018 Nov; 18(1):295. PubMed ID: 30497404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deprescribing Antihypertensive Medications for Patients Aged 80 Years or Older: Is Doing Less Doing No Harm?
    Peterson ED; Rich MW
    JAMA; 2020 May; 323(20):2024-2026. PubMed ID: 32453349
    [No Abstract]   [Full Text] [Related]  

  • 19. Deprescribing medications in older people: a narrative review.
    Salahudeen MS
    Drugs Today (Barc); 2018 Aug; 54(8):489-498. PubMed ID: 30209443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frailty, polypharmacy and deprescribing.
    Drug Ther Bull; 2016 Jun; 54(6):69-72. PubMed ID: 27284125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.